TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Secured Loans History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Secured Loans | ₹11,651 Cr | ₹1,192 Cr | ₹1,604 Cr | ₹2,496 Cr | ₹2,123 Cr |
What is the latest Secured Loans ratio of TORRENT PHARMACEUTICALS ?
| Year | Secured Loans |
|---|---|
| Mar2026 | ₹11,651 Cr |
| Mar2025 | ₹1,192 Cr |
| Mar2024 | ₹1,604 Cr |
| Mar2023 | ₹2,496 Cr |
| Mar2022 | ₹2,123 Cr |
How is Secured Loans of TORRENT PHARMACEUTICALS Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2026 | ₹11,651 Cr | 877.65 | |
| Mar2025 | ₹1,192 Cr | -25.69 | |
| Mar2024 | ₹1,604 Cr | -35.75 | |
| Mar2023 | ₹2,496 Cr | 17.57 | |
| Mar2022 | ₹2,123 Cr | - | |
Compare Secured Loans of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹175,197.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
| MANKIND PHARMA | ₹103,286.0 Cr | 9.6% | 1% | -6.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 1.7% |
-6.7% |
28% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses